Search PDMR transactions

Notifier
Name of person with notification obligation
Staffan Strömberg
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Staffan Strömberg
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
INFANT BACTERIAL THERAPEUTICS AB
Issuer´s LEI code
2138008KVBXCRJGP6Z26
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Infant Bacterial Therapeutics AB ser. B SE0008015259 Acquisition 1,500 Quantity 96.70 SEK 04/05/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Infant Bacterial Therapeutics AB ser. B SE0008015259 Acquisition 04/05/2021 NASDAQ STOCKHOLM AB 1,500 (Quantity) 96.70 SEK
<< Back